These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34198482)

  • 1. The Role of Non-Enzymatic Degradation of Meropenem-Insights from the Bottle to the Body.
    Liebchen U; Rakete S; Vogeser M; Arend FM; Kinast C; Scharf C; Zoller M; Schönermarck U; Paal M
    Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34198482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An isotope-dilution LC-MS/MS method for the simultaneous quantification of meropenem and its open-ring metabolite in serum.
    Rakete S; Schuster C; Paal M; Vogeser M
    J Pharm Biomed Anal; 2021 Apr; 197():113944. PubMed ID: 33588299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis.
    Kuti JL; Nightingale CH; Knauft RF; Nicolau DP
    Clin Ther; 2004 Apr; 26(4):493-501. PubMed ID: 15189746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LC.
    Robatel C; Buclin T; Eckert P; Schaller MD; Biollaz J; Decosterd LA
    J Pharm Biomed Anal; 2002 Jun; 29(1-2):17-33. PubMed ID: 12062661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures.
    Franceschi L; Cojutti P; Baraldo M; Pea F
    Ther Drug Monit; 2014 Oct; 36(5):674-6. PubMed ID: 24637698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.
    Ehmann L; Zoller M; Minichmayr IK; Scharf C; Maier B; Schmitt MV; Hartung N; Huisinga W; Vogeser M; Frey L; Zander J; Kloft C
    Crit Care; 2017 Oct; 21(1):263. PubMed ID: 29058601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative LC-MS/MS and HPLC-UV Analyses of Meropenem and Piperacillin in Critically Ill Patients.
    Paal M; Heilmann M; Koch S; Bertsch T; Steinmann J; Höhl R; Liebchen U; Schuster C; Kleine FM; Vogeser M
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.
    Fawaz S; Barton S; Whitney L; Swinden J; Nabhani-Gebara S
    Hosp Pharm; 2019 Jun; 54(3):190-196. PubMed ID: 31205331
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability of meropenem in normal saline solution after storage at room temperature.
    Jaruratanasirikul S; Sriwiriyajan S
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):627-9. PubMed ID: 15115140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial.
    Onichimowski D; Będźkowska A; Ziółkowski H; Jaroszewski J; Borys M; Czuczwar M; Wiczling P
    Pharmacol Rep; 2020 Jun; 72(3):719-729. PubMed ID: 32301057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/MS-ESI method for simultaneous quantification of darolutamide and its active metabolite, ORM-15341 in mice plasma and its application to a pharmacokinetic study.
    Dittakavi S; Nagasuri PKVSP; Sulochana SP; Saim SM; Mallurwar SR; Zainuddin M; Dewang P; Rajagopal S; Mullangi R
    J Pharm Biomed Anal; 2017 Oct; 145():454-461. PubMed ID: 28743076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of meropenem in critically ill children with different renal functions.
    Rapp M; Urien S; Foissac F; Béranger A; Bouazza N; Benaboud S; Bille E; Zheng Y; Gana I; Moulin F; Lesage F; Renolleau S; Tréluyer JM; Hirt D; Oualha M
    Eur J Clin Pharmacol; 2020 Jan; 76(1):61-71. PubMed ID: 31654149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: Quantitative method and identification of degradation products.
    de Souza Barbosa F; Capra Pezzi L; Tsao M; Dias Macedo SM; de Oliveira TF; Schapoval EES; Mendez ASL
    J Pharm Biomed Anal; 2020 Feb; 179():112973. PubMed ID: 31732407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preanalytical Stability of Piperacillin, Tazobactam, Meropenem, and Ceftazidime in Plasma and Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry.
    Mortensen JS; Jensen BP; Zhang M; Doogue M
    Ther Drug Monit; 2019 Aug; 41(4):538-543. PubMed ID: 31306394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
    Ververs TF; van Dijk A; Vinks SA; Blankestijn PJ; Savelkoul JF; Meulenbelt J; Boereboom FT
    Crit Care Med; 2000 Oct; 28(10):3412-6. PubMed ID: 11057794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 2: Stability Evaluation.
    D'Cunha R; Bach T; Young BA; Li P; Nalbant D; Zhang J; Winokur P; An G
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device.
    Smith DL; Bauer SM; Nicolau DP
    Am J Health Syst Pharm; 2004 Aug; 61(16):1682-5. PubMed ID: 15540479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures.
    Ezquer-Garin C; Ferriols-Lisart R; Martinez-López LM; Sangrador-Pelluz C; Nicolás-Picó J; Alós-Almiñana M
    Pharmazie; 2020 May; 75(5):172-176. PubMed ID: 32393422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.